VNN1 and cardiovascular disorder: Future studies should prioritize the simultaneous measurement of both PA and cysteamine, alongside relevant markers of oxidative stress like GSH, to gain a more comprehensive understanding of the vanin-1 pathway’s role in metabolic and cardiovascular diseases and to fully explore the potential for a dichotomic mechanism.